Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: SEAGEN INC.
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02401347 | SEAGEN INC. | ADCETRIS | Human | Yes | Prescription | 1 | BRENTUXIMAB VEDOTIN | 50 MG / VIAL |
Marketed | 02401347 | SEAGEN INC. | ADCETRIS | Human | Yes | Schedule D | 1 | BRENTUXIMAB VEDOTIN | 50 MG / VIAL |
Marketed | 02521903 | SEAGEN INC. | PADCEV | Human | Yes | Prescription | 1 | ENFORTUMAB VEDOTIN | 20 MG / VIAL |
Marketed | 02521903 | SEAGEN INC. | PADCEV | Human | Yes | Schedule D | 1 | ENFORTUMAB VEDOTIN | 20 MG / VIAL |
Marketed | 02521911 | SEAGEN INC. | PADCEV | Human | Yes | Prescription | 1 | ENFORTUMAB VEDOTIN | 30 MG / VIAL |
Marketed | 02521911 | SEAGEN INC. | PADCEV | Human | Yes | Schedule D | 1 | ENFORTUMAB VEDOTIN | 30 MG / VIAL |
Marketed | 02499827 | SEAGEN INC. | TUKYSA | Human | Yes | Prescription | 1 | TUCATINIB | 50 MG |
Marketed | 02499835 | SEAGEN INC. | TUKYSA | Human | Yes | Prescription | 1 | TUCATINIB | 150 MG |
Application information
Related information
Contact us
Version 4.0.3